Diagnosis of porphyric syndromes: A practical approach in the era of molecular biology

Seminars in Liver Disease

Volumn 18, Issue 1, 1998, Pages 57-65

  Bonkovsky, Herbert L ^a   Barnard, Graham F ^a  

^a UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

Author keywords

5 aminolevulinate; Diagnostic testing; Enzymatic assays; Lead poisoning; Molecular diagnostic studies; Porphobilinogen; Porphyrias; Porphyrins

Indexed keywords

5 AMINOLEVULINATE SYNTHASE; PORPHOBILINOGEN;

ARTICLE; COST EFFECTIVENESS ANALYSIS; DIAGNOSTIC TEST; DNA DETERMINATION; ENZYME ASSAY; ENZYME DEFICIENCY; HUMAN; LEAD POISONING; PORPHYRIA; PRIORITY JOURNAL; SCREENING TEST; SOLAR URTICARIA;

EID: 0031892865     PISSN: 02728087     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2007-1007141     Document Type: Article

References (30)

1. Watson CJ, Schwartz S. A simple test for urinary porphobilinogen. Proc Soc Exp Biol Med 1941;47:393
2. Lamon J, With T, Redeker A. The Hoesch test: bedside screening for urinary porphobilinogen in patients with suspected porphyria. Clin Chem 1974;20:1438-1440
3. Bonkovsky H. The Porphyrias. In Conn RB (ed): Current Diagnosis. Philadelphia, WB Saunders, 1991, pp 799-804
4. Mauzerall D, Granick S. Occurrence and determination of 5-aminolaevulinic acid and porphobilinogen in urine J Biol Chem 1956;219:435-446
5. Schwartz S, Edmondson P, Stephenson B. Direct spectrofluorometric determination of porphyrin in diluted urine. Ann Clin Res 1976;8(suppl 17):156-161
6. Lockwood WH, Poulos V, Rossi E, Curnow DH. Rapid procedure for fecal porphyrin assay. Clin Chem 1985;31:1163-1167
7. Schwartz S, Berg MH, Bossenmaier I, Dinsmore H. Determination of porphyrins in biological materials. Meth Biochem Anal 1962;8:221-293
8. Bonkovsky HL, Wood SG, Howell SK, et al. HPLC Separation and quantitation of tetrapyrroles from biological materials. Analyt Biochem 1986;155:56-64
9. Poh-Fitzpatrick M. A plasma porphyrin fluorescence marker for variegate porphyria. Arch Dermatol 1980;116:543-547
10. Goetsch CA, Bissell DM Instability of hematin used in the treatment of hepatic porphyria. N Engl J Med 1986;315:235-238
11. Bonkovsky HL, Healey J, Lourie AN, Gerron GG. Intravenous heme-albumin in acute intermittent porphyria. Amer J Gastroenterol 1991;86:1050-1056
12. Pierach CA. Hematin therapy for the porphyric attack. Semin Liv Dis 1992;2:125-131
13. Dover SB, Moore MR, Fitzsimmons EJ, et al. Tin protoporphyrin prolongs the biochemical remission produced by heme arginate in acute hepatic porphyria. Gastroenterology 1993;105: 500-506
14. Bonkovsky HL. Advances in understanding and treating 'the little imitator,' acute porphyria. Gastroenterology 1993;105:590-594
15. Bonkovsky HL, Tschudy DP, Collins A, et al. Repression of the overproduction of porphyrin precursors in acute intermittent porphyria by intravenous infusions of hematin. Proc Natl Acad of Sci USA 1971;62 2725-2729
16. Logan GM, Weimer MK, Ellefson J, et al. Bile porphyrin analysis in the evaluation of variegate porphyria. N Engl J Med 1991;324:1408-1411
17. Hahn M, Bonkovsky HL. Multiple chemical sensitivity syndrome and porphyria: a note of caution and concern. Arch Int Med 1997;127:281-285
18. Meissner PN, Dailey TA, Hift RJ, et al. A R59W mutation in human protoporphyrinogen oxidase results in decreased enzyme activity and is prevalent in South Africans with variegate porphyria. Nat Genet 1996;13:95-97
19. Plewinska M, Thunell S, Holmberg L, et al. Delta-aminolevulinate dehydratase deficient porphyria: identification of the molecular lesions in a severely affected homozygote. Amer J Human Genet 1991;49:167-174
20. Garey JR, Hansen JL, Harrison LM, et al. A point mutation in the coding region of uroporphyrinogen decarboxylase associated with familial porphyria cutanea tarda. Blood 1989;73:892-895
21. Kauppinen R, Mustajoki S, Pihlaja H, et al. Acute intermittent porphyria in Finland: 19 mutations in the porphobilinogen deaminase gene. Hum Molec Genet 1995;4:215-222
22. Mgone CS, Lanyon WG, Moore MR, et al. Identification of five novel mutations in the porphobilinogen deaminase gene. Hum Molec Genet 1994;3:809-811
23. Lee JS, Anvret M. Identification of the most common mutation within the porphobilinogen deaminase gene in Swedish patients with acute intermittent porphyria. Proc Natl Acad Sci USA 1991;88:10912-10915
24. Lundin G, Wedell A, Thunell S, Anvret M. Two new mutations in the porphobilinogen deaminase gene and a screening method using PCR amplication of specific alleles. Hum Genet 1994; 93:59-62
25. Fontanellas A, Bensidhoum M, Desalamanca RE, et al. A systematic analysis of the mutations of uroporphyrinogen III synthase in congenital erythropoietic porphyria. Euro J Human Genetics 1996;4:274-282
26. Lee JS, Lundin G, Lannfelt L, et al. Genetic heterogeneity of the porphobilinogen deaminase gene in Swedish families with acute intermittent porphyria. Hum Genet 1991;87:484-488
27. Andersson C, Thunell S, Floderus Y, et al. Diagnosis of acute interrnittent porphyria in northern Sweden: an evaluation of mutation analysis and biochemical methods. J Int Med 1995;237: 301-308
28. Schreiber WE, Jamani A, Armstrong JG. Acute intermittent porphyria in a native North American family. Biochemical and molecular analysis. Ameri J Clini Pathol 1995;103:730-734
29. Sassa S. Diagnosis and therapy of AIP. Blood Rev 1996;10:53-58
30. Whatley SC. De-novo mutation and sporadic presentation of acute intermittent porphyria. Lancet 1995;346:1007-1008